In Billing
Mar 11th, 2011
A claims processing issue has resulted in claims for HCPCS Level II code J9395 Fulvestrant, 25 mg with dates of service on or after Jan. 1 to be improperly paid by at least one Medicare administrative contractor (MAC). The Centers for Medicare & Medicaid Services (CMS) recently discovered that providers were being underpaid for these ...
In Coding
Oct 1st, 2010
New dosage and administration technique recommendations for FASLODEX® were approved by the U.S. Food and Drug Administration (FDA) Sept. 10. New Dosing for FASLODEX Injections was last modified: July 5th, 2011 by admin aapc...